Real-time enrollment status for this primary membranous nephropathy clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 12:46 AM UTC
| NCT Number | NCT07204275 |
| Recruiting Status | Recruiting |
| Condition | Primary Membranous Nephropathy |
| Phase | PHASE2 |
| Target Enrollment | 176 participants |
| Active Locations | 24 sites in the US |
| Sponsor | Vertex Pharmaceuticals Incorporated |
| Last Updated on CT.gov | August 3, 2026 (3 weeks ago) |
As of August 28, 2026: Clinical trial NCT07204275 is currently recruiting participants. This phase2 study for primary membranous nephropathy is actively seeking new participants at 24 locations across the United States. The study is sponsored by Vertex Pharmaceuticals Incorporated. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07204275 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07204275 was last updated 3 weeks ago (August 3, 2026). HelloStudys verifies this status automatically.